What Maze Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 36 | 91 |
| Total trades | 46 | 140 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 162,892 | 535,452 |
| Disposed | 244,113 | 2,298,613 |
| Net activity | −81,221 | −1,763,161 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Courtney Phillips | GC and Corp. Secretary | Sep 03 | Open-market sale · S | −22 | $25.78 | −$567 | 7,007 |
| Courtney Phillips | GC and Corp. Secretary | Sep 03 | Open-market sale · S | −1,990 | $26.01 | −$51.8K | 7,029 |
| Dandekar Atul | CSBO | Sep 03 | Open-market sale · S | −36 | $25.81 | −$929 | 32,316 |
| Dandekar Atul | CSBO | Sep 03 | Open-market sale · S | −3,207 | $26.01 | −$83.4K | 32,352 |
| Coloma Jason V | Chief Executive Officer | Sep 03 | Open-market sale · S | −129 | $25.77 | −$3.32K | 27,362 |
| Coloma Jason V | Chief Executive Officer | Sep 03 | Open-market sale · S | −11,282 | $26.01 | −$293K | 27,491 |
| Bernstein Harold | President, R&D & CMO | Sep 03 | Open-market sale · S | −59 | $25.78 | −$1.52K | 9,705 |
| Bernstein Harold | President, R&D & CMO | Sep 03 | Open-market sale · S | −5,130 | $26.01 | −$133K | 9,764 |
| Courtney Phillips | GC and Corp. Secretary | Sep 02 | Open-market sale · S | −243 | $27.12 | −$6.59K | 9,019 |
| Courtney Phillips | GC and Corp. Secretary | Sep 02 | Open-market sale · S | −1,738 | $26.38 | −$45.8K | 9,262 |
| Dandekar Atul | CSBO | Sep 02 | Open-market sale · S | −391 | $27.12 | −$10.6K | 35,559 |
| Dandekar Atul | CSBO | Sep 02 | Open-market sale · S | −2,800 | $26.38 | −$73.9K | 35,950 |
| Coloma Jason V | Chief Executive Officer | Sep 02 | Open-market sale · S | −1,375 | $27.12 | −$37.3K | 38,773 |
| Coloma Jason V | Chief Executive Officer | Sep 02 | Open-market sale · S | −9,852 | $26.38 | −$260K | 40,148 |
| Bernstein Harold | President, R&D & CMO | Sep 02 | Open-market sale · S | −625 | $27.12 | −$17K | 14,894 |
| Bernstein Harold | President, R&D & CMO | Sep 02 | Open-market sale · S | −4,481 | $26.38 | −$118K | 15,519 |
| Courtney Phillips | GC and Corp. Secretary | Sep 01 | Exercise / conversion · M | +11,000 | — | — | 11,000 |
| Coloma Jason V | Chief Executive Officer | Sep 01 | Exercise / conversion · M | +50,000 | — | — | 50,000 |
| Coloma Jason V | Chief Executive Officer | Sep 01 | Open-market sale · S | −31,908 | $26.29 | −$839K | 223,355 |
| Coloma Jason V | Chief Executive Officer | Sep 01 | Open-market sale · S | −2,593 | $26.31 | −$68.2K | 18,151 |
Loading...